By The Source -

FDA-Approved Asthma Inhaler Will Be Phased Out

www.rttnews.com

The Primatene Mist epinephrine asthma inhaler will be pulled out from the market and will no longer be available in in 2012, according to FDA. The agency has decided to ban this asthma inhaler because it contains chlorofluorocarbons.

This decision is part of the international agreement by the US and other countries to stop the production of certain substances that can destroy ozone layers.

(RTTNews) – Primatene Mist, the only FDA-approved epinephrine asthma inhaler, sold over the counter in the United States will no longer be available after December 31, 2011, as the FDA has decided to ban chlorofluorocarbons-containing inhalers.

The phase out of the chlorofluorocarbons-containing inhalers is part of an international agreement signed by the United States and many countries to ban the manufacture and sale of substances that decrease the ozone layer, including chlorofluorocarbons, or CFCs, after certain dates.

Read the entire article here:

http://www.rttnews.com/Content/TopStories.aspx?Id=1720014&SM=1

 

 

4 Responses to “FDA-Approved Asthma Inhaler Will Be Phased Out”

  1. Joyce B
    October 17, 2011 at 7:28 pm

    I am a 59 yr old, Af Am, female, who has used Primatene Mist Inhaler for many years (7)… with NO side effects. I have also used Albuterol Inhalers and have suffered repeated Asthma episodes and exacerbation also ulcerative colitis (read the contraindicators). Therefore leading one to have to take steroids, which is very harmful for the overall system of the body. I now have spots before my eyes because of Steroids called (floaters). Dr’s have told me of the horrors of using this Ephnephrine, but no heart problems or palpitations have ever occured. In my opinion the medical community has been brain washed by the drug companies. It’s a lot more convenient to purchase PRIMATENE at the store than to have to go to the doctor and pay their fee as well as a fee for the Albuterol, which everybody with Asthma is taking. Have you ever had a pharmacist tell you they could not fill your order of Albuterol because of the high demand? There are seasons when Asthmatics have difficulty and medications are in high demand at that time. I see this as another attempt by the drug companies to control or monopolize the market and we have no alternatives to their manipulation of the media for “safe” over the counter remedies that are competitive. What are you going to do at 3am and can’t get your script filled and you no longer have health insurance and just maybe the hospital will take you ahead of everyone and give you a breathing treatment with ALBUTEROL? You could have saved time, money and space at the hospital with your PRIMATENE MIST INHALER- but you don’t have that OPTION now!!

  2. John L.
    January 16, 2012 at 8:15 am

    Used PM for a lot of years, from age 16 to 50 (now 51). No complications, great product, quick relief, no hassles. Sorry to see it go.

  3. kim
    January 22, 2012 at 12:15 am

    before they took that away i think they should have come up with a replacement for people like me who cant afford to go the doctor.

  4. Chuck
    February 1, 2012 at 8:38 pm

    So what in the wide world of sports is Primatene doing to replace the chlorofluorocarbon with something that will work within the expectable regulations for this product and get the inhaler back on the shelves? Instead of banning the product that is so widely in demand, I think that the US Gov. should help Primatene out with whatever they need to make whatever changes that are required.They helped out the car manufactures and look at what the auto does to the ozone layer. Doesn’t Primatene rate for a bailout, or are they not a large enough company? The gov. does seem a bit self-serving at times. I have use this product for many years. I like the product. It’s fast acting with no side affects to me and I could purchase it at any pharmacy at any time. I wish Primatene all the luck and hope this problem gets resolved quickly. I would love to see this product back on the market.

Leave a Reply